Dr. Sheffield Triple Antibiotic Ointment, OTC a) 0.33 oz (9g) (NDC 11527-162-47); b) 1 oz (22g) (NDC 11527-163-55) SHEFFIELD PHARMACEUTICALS, New London, CT 06320
Published February 12, 2014 · Recall initiated: November 22, 2013
Summary
FDA records drug Class II recall D-1076-2014, published February 12, 2014 and initiated November 22, 2013. Recalling firm: Faria Limited LLC dba Sheffield Pharmaceuticals; Status: Terminated; Reported quantity: 332508; Lot: 20154 EXP.12/13, 20153 EXP.12/13, 20152 EXP.12/12, 20151 EXP.12/11, 20093 EXP.12/13, 20092 EXP.12/13, 20091 EXP.12/13, 20085 EXP.12/13, 20084 EXP.12/13, 20083 EXP. 2/13, 20082 EXP.12/13, 20073 EXP. 12/13, 20074 EXP. 12/13, 20075 EXP. 12/13, 20081 EXP.12/13, 20021 EXP. 12/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found during environmental testing
What to do
Voluntary: Firm initiated · Letter
Get an email if SHEFFIELD TRIPLE ANTIBIOTIC has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SHEFFIELD TRIPLE ANTIBIOTIC
- Manufacturer
- Faria Limited LLC dba Sheffield Pharmaceuticals
- Distributor
- Nationwide
- Lot
- 20154 EXP.12/13, 20153 EXP.12/13, 20152 EXP.12/12, 20151 EXP.12/11, 20093 EXP.12/13, 20092 EXP.12/13, 20091 EXP.12/13, 20085 EXP.12/13, 20084 EXP.12/13, 20083 EXP. 2/13, 20082 EXP.12/13, 20073 EXP. 12/13, 20074 EXP. 12/13, 20075 EXP. 12/13, 20081 EXP.12/13, 20021 EXP. 12/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHydralazine HCL Tablets, USP, 50 mg in a single blister package, Rx only, Manufactured in Czech Republic by:February 12, 2014
- FDAFAMILY wellness Triple Antibiotic Ointment. NET WT 1 OZ (28 g), OTC, DISTRIBUTED BY: FAMILY DOLLAR SERVICES,February 12, 2014
- FDAHydralazine HCL Tablets, USP, 25 mg in a single blister package, Manufactured in Czech Republic By: Teva CzechFebruary 12, 2014
- FDADollar General Triple Antibiotic Ointment; NET WT 1 OZ (28 g), OTC, DISTRIBUTED BY DOLGENCORP LLC,February 12, 2014
- FDATimolol Maleate Sterile Ophthalmic Solution, USP 0.5%, 10mL, (NDC 16571-141-10). The products are packaged inFebruary 12, 2014
- FDAPyridostigmine Bromide Tablets USP, 60 mg, 100 count bottle, Rx only, Manufactured and Distributed by:February 12, 2014
Questions about this recall
Was Dr. Sheffield Triple Antibiotic Ointment, OTC a) 0.33 oz (9g) (NDC 11527-162-47); b) 1 oz (22g) (NDC 11527-163-55) SHEFFIELD PHARMACEUTICALS, New London, CT 06320 recalled?
Yes. FDA published recall D-1076-2014 on February 12, 2014. Reported hazard: Microbial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found during environmental testing
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SHEFFIELD TRIPLE ANTIBIOTIC.